Sun Pharma gains Australian approval for Acne treatment Winlevi
Sun Pharmaceutical Industries Limited (Sun Pharma) has achieved a significant milestone in dermatology with the Australian Therapeutic Goods Administration (TGA)’s recent approval of Winlevi (clascoterone cream 1%). Indicated for the topical treatment of acne vulgaris in patients aged 12 and older, Winlevi introduces a novel mechanism of action to the Australian market, enriching Sun Pharma’s […]